Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.9940
-0.0360 (-3.50%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Lineage Cell Therapeutics Employees
As of December 31, 2025, Lineage Cell Therapeutics had 77 total employees, including 70 full-time and 7 part-time employees. The number of employees did not change compared to the previous year. That makes Lineage Cell Therapeutics the 32,909th largest employer in the world and 4,291st in the United States.
Employees
77
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$169,909
Profits / Employee
-$418,961
Market Cap
251.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 77 | 0 | - | 72 | 5 |
| Dec 31, 2024 | 77 | 2 | 2.67% | 70 | 7 |
| Dec 31, 2023 | 75 | -3 | -3.85% | 68 | 7 |
| Dec 31, 2022 | 78 | 17 | 27.87% | 70 | 8 |
| Dec 31, 2021 | 61 | 6 | 10.91% | 57 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Sutro Biopharma | 128 |
| Nautilus Biotechnology | 127 |
| Zentalis Pharmaceuticals | 106 |
| Century Therapeutics | 78 |
| Pyxis Oncology | 56 |
| Camp4 Therapeutics | 48 |
| Vicore Pharma Holding AB | 46 |
LCTX News
- 4 weeks ago - Lineage Cell announces issuance of patent underlying AlloSCOPE 5D platform - TheFly
- 4 weeks ago - Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform - Business Wire
- 6 weeks ago - Lineage Cell Therapeutics management to meet with B. Riley - TheFly
- 2 months ago - Lineage Cell Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Lineage Cell Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Lineage Cell Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c) - TheFly
- 2 months ago - Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire